Who
David McClung
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, BioCardia.
In numbers
- Trades disclosed
- 46
- Buys
- 8
- Sells
- 0
- Bought
- $54K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Feb 2018
- Last trade
- 6 Jul 2026
- Last filed
- 7 Jul 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 6 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,501 at $0.00 | filing |
| 6 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,501 at $0.00 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $29K23,125 at $1.24 | filing |
| 2 Jul 2026filed 7 Jul 2026 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $29K23,125 at $1.24 | filing |
| 29 Jun 2026filed 1 Jul 2026 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $73K60,483 at $1.20 | filing |
| 29 Jun 2026filed 1 Jul 2026 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $73K60,483 at $1.20 | filing |
| 8 Dec 2025filed 10 Dec 2025 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —27,000 at $0.00 | filing |
| 8 Dec 2025filed 10 Dec 2025 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $80K58,276 at $1.37 | filing |
| 8 Dec 2025filed 10 Dec 2025 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $40K29,339 at $1.37 | filing |
| 30 Jun 2025filed 2 Jul 2025 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code P | —4,819 | filing |
| 30 Jun 2025filed 2 Jul 2025 | BCDA BioCardiaBiotechnology | SEC FORM 4 Bought | $10K4,819 at $2.08 | filing |
| 23 Apr 2025filed 25 Apr 2025 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code P | —13,123 | filing |
| 23 Apr 2025filed 25 Apr 2025 | BCDA BioCardiaBiotechnology | SEC FORM 4 Bought | $25K13,123 at $1.91 | filing |
| 11 Oct 2024filed 16 Oct 2024 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $64K24,193 at $2.65 | filing |
| 11 Oct 2024filed 16 Oct 2024 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $31K11,565 at $2.65 | filing |
| 3 Sep 2024filed 5 Sep 2024 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,333 | filing |
| 3 Sep 2024filed 5 Sep 2024 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $25K8,333 at $3.00 | filing |
| 23 Jun 2023filed 26 Jun 2023 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code A | $10K4,280 at $2.34 | filing |
| 31 May 2023filed 2 Jun 2023 | BCDA BioCardiaBiotechnology | SEC FORM 4 Code F | $37K20,676 at $1.77 | filing |
| 18 May 2023filed 22 May 2023 | BCDA BioCardiaoption or derivative · Biotechnology | SEC FORM 4 Code A | —68,265 at $0.00 | filing |
News
BioCardia (NASDAQ:BCDA) Stock Falls 5.5% – What's Next?BCDA · dailypolitical.com · 23 Oct 2026BioCardia Advances Helix Catheter Toward FDA Marketing ClearanceBCDA · rttnews.com · 19 Oct 2026
0 headlines in the last 90 days name David McClung; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.